首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Medicine >Our experience of 200 patients: usage and maintenance of long-term oxygen therapy and non-invasive ventilation devices at home
【2h】

Our experience of 200 patients: usage and maintenance of long-term oxygen therapy and non-invasive ventilation devices at home

机译:我们在200名患者中的经验:在家中长期氧气疗法和无创通气设备的使用和维护

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: To evaluate the patients’ attitudes about the devices, of which they use for long-term respiratory support at home. Method: 200 consecutive patients were questioned about the treatment and devices of respiratory support at home by face to face questionnaire. Their records were taken from the archives of Social Security Agency. Results: 123 (61.5%) of the patients were men and 77 (38.5%) were women. The mean age was 65.8 ± 11.9 (15-92) years. The most frequently prescribed device was oxygen concentrator and BIPAP was the one that follows. The most common indications were hypoxic and hypercapnic respiratory failure due to COPD. The devices were prescribed by the state university hospitals, most commonly. The average daily oxygen usage duration was 16.3 ± 3.1 hours, the average duration was 7.4 ± 3.1 hours, for BIPAP. Twenty one (11.4%) of the patients, who were treated with LTOT, stated that they were taking oxygen less than 15 hours a day. Higher education levels of the patients was correlated with the higher rates of visiting the companies - that they bought the devices- both for information about and control of the devices (p=0.002). The rate of visiting companies/firms was significantly higher in patients, who use BIPAP and respiratory support combined with it (p=0.010). Twenty three (47.9%) of the 48 patients, who notified that their devices were impaired, waited for repairment by the firm, 20 (41.6%) investigated special repair facilities and the rest (10.5%) rented a new device. Conclusion: Effective and continuous technical maintenance support must be provided to the patients, who are treated with long-term respiratory support at home.
机译:目的:评估患者对设备的态度,他们将其用于在家中的长期呼吸支持。方法:通过面对面的问卷调查连续200名患者在家中呼吸支持的治疗和设备。他们的记录来自社会保障局的档案。结果:123名患者(61.5%)为男性,77名患者(38.5%)为女性。平均年龄为65.8±11.9(15-92)岁。处方最频繁的设备是氧气浓缩器,随后是BIPAP。最常见的适应症是由于COPD引起的低氧和高碳酸血症性呼吸衰竭。设备最常见的是由州立大学医院开具的处方。对于BIPAP,平均每日耗氧时间为16.3±3.1小时,平均耗时为7.4±3.1小时。接受LTOT治疗的患者中有21名(11.4%)表示每天服用氧气少于15小时。患者的受教育程度与访问公司(购买设备)以获取有关设备信息和控制设备的较高访问率相关(p = 0.002)。使用BIPAP和呼吸支持相结合的患者中,访问公司/公司的比率显着更高(p = 0.010)。在48位患者中,有23位(47.9%)通知他们的设备已损坏,等待公司维修,有20位(41.6%)对特殊维修设施进行了调查,其余(10.5%)租用了新设备。结论:必须为在家中接受长期呼吸支持的患者提供有效和持续的技术维护支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号